Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/14570
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.contributor.authorBrasil. Ministério da Saúde-
dc.contributor.authorSistema Único de Saúde (Brasil)-
dc.date.accessioned2023-08-08T15:18:54Z-
dc.date.available2023-08-08T15:18:54Z-
dc.date.issued2022-12-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/14570-
dc.description2 p.pt_BR
dc.language.isoporpt_BR
dc.publisherINCA-
dc.relation.ispartofseriesAno VI, n. 68.-
dc.subjectNeoplasias Cutâneas/diagnósticopt_BR
dc.subjectSkin Neoplasms/diagnosispt_BR
dc.subjectNeoplasias Cutáneas/diagnósticopt_BR
dc.subjectTerapia Neoadjuvantept_BR
dc.subjectNeoadjuvant Therapypt_BR
dc.subjectTerapia Neoadyuvantept_BR
dc.titlePortaria Conjunta n.o 19 /SAES e SCTIE/MS, de 25 de outubro de 2022pt_BR
dc.TypeOtherpt_BR
Appears in Collections:Informe SUS - ONCO 2022

Files in This Item:
File Description SizeFormat 
informe-sus-onco-dezembro_2022_0.pdf465.67 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.